Oral antifungal drug interactions

Dermatologic Clinics

Volumn 15, Issue 3, 1997, Pages 535-544

  Katz, H I ^a   Gupta, A K ^a  

^a Minnesota Clinical Study Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTACID AGENT; ASTEMIZOLE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CISAPRIDE; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DIGOXIN; FLUCONAZOLE; GLIBENCLAMIDE; GLIPIZIDE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MEVINOLIN; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; QUINIDINE; QUINIDINE SULFATE; TACROLIMUS; TERBINAFINE; TERFENADINE; TOLBUTAMIDE; TRIAZOLAM; UNINDEXED DRUG; VINCRISTINE SULFATE; WARFARIN;

BLEEDING; CARDIOTOXICITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MYOPATHY; NEPHROTOXICITY; ONYCHOMYCOSIS; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SOMNOLENCE;

EID: 0030991548     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70460-5     Document Type: Article

References (92)

1. P.S. Albright J. Bruni Pharmacokinetic interactions of antiepileptic drugs Can J Neurol Sci 11 1984 247 251
2. Allegra package insert prescribing information 1996 Hoechst Marion Roussel Kansas City, MO
3. W.K. Andersen D.S. Feingold Adverse drug interactions clinically important for the dermatologist Arch Dermatol 131 1995 468 473
4. Anonymous Canadian Adverse Drug Reaction Newsletter 6 1996 1 3
5. G. Apseloff D.M. Hilligoss M.J. Gardner Induction of fluconazole metabolism by rifampin: In vivo study in humans J Clin Pharmacol 31 1991 358 361
6. R. Assan G. Fredj E. Larger FK 506/fluconazole interaction enhances FK 506 nephrotoxicity Diabetes Metab 20 1994 49 52
7. A.M. Baciewicz F.A. Baciewicz Jr Ketoconazole and fluconazole drug interactions [see comments] Arch Intern Med 153 1993 1970 1976
8. A.M. Baciewicz J.J. Menke J.A. Bokar Fluconazole-warfarin interaction [letter] Ann Pharmacother 28 1994 1111
9. D.J. Back P. Stevenson J.F. Tjia Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro Br J Clin Pharmacol 28 1989 166 170
10. Biaxin package insert prescribing information 1996 Abbott Laboratories North Chicago, IL
11. D.R. Bickers Antifungal therapy: Potential interactions with other classes of drugs J Am Acad Dermatol 31 1994 S87 S90
12. M. Blomley E.L. Teare A. de Belder Itraconazole and anti-tuberculosis drugs [letter; comment] Lancet 336 1990 1255
13. J.A. Bloom J.W. Frank M.S. Shafir Potentially undesirable prescribing and drug use among the elderly. Measurable and remediable [see comments] Can Fam Physician 39 1993 2337 2345
14. A. Bohme A. Ganser D. Hoelzer Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL Ann Hematol 71 1995 311 312
15. M. Bonay A.P. Jonville-Bera P. Diot Possible interaction between phenobarbital, carbamazepine and itraconazole Drug Safety 9 1993 309 311
16. A. Breckenridge Clinical significance of interactions with antifungal agents [review] Br J Dermatol 126 Suppl 39 1992 19 22
17. M.W. Brown A.L. Maldonado C.G. Meredith Effect of ketoconazole on hepatic oxidative drug metabolism Clin Pharmacol Ther 37 1985 290 297
18. Carafate package insert prescribing information 1995 Hoechst Marion Roussel Kansas City, MO
19. P.L. Carver R.R. Berardi M.J. Knapp In vivo interaction of ketoconazole and sucralfate in healthy volunteers Antimicrob Agents Chemother 38 1994 326 329
20. Claritin package insert prescribing information 1995 Schering Corporation Kenilworth, NJ
21. L.J. Cohen Principles to optimize drug treatment in the depressed elderly: Practical pharmacokinetics and drug interactions Geriatrics 50 Suppl 1 1995 S32 S40
22. R.J. Coker D.R. Tomlinson J. Parkin Interaction between fluconazole and rifampicin BMJ 301 1990 818
23. C.A. Colley L.M. Lucas Polypharmacy: The cure becomes the disease J Gen Intern Med 8 1993 278 283
24. Crixivan package insert prescribing information 1996 Merck & Company West Point, PA
25. L.L. Crussell-Porter J.P. Rindone M.A. Ford Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium [see comments] Arch Intern Med 153 1993 102 104
26. S.I. Cullen P.M. Catalano Griseofulvin-warfarin antagonism JAMA 199 1967 582 583
27. T.K. Daneshmend D.W. Warnock Clinical pharmacokinetics of ketoconazole Clin Pharmacokinet 14 1988 13 34
28. De Doncker P, Van de Velde V, De Coster R, et al: No indication of decrease in plasma levels of oral contraceptives after 15 days of itraconazole administration in premenopausal women [poster]. 55th Annual Meeting of the American Academy of Dermatology, March 21–26, 1997
29. Deltasone package insert prescribing information 1995 Pharmacia & Upjohn Company Kalamazoo, MI
30. Diflucan package insert prescribing information 1996 Pfizer New York, NY
31. J. Drayton G. Dickinson M.G. Rinaldi Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole [letter] Clin Infect Dis 18 1994 266
32. F. Dunbar Cisapride labelling change [letter] S Afr Med J 85 1995 287 288
33. D.L. Fett L.F. Vukov An unusual case of severe griseofulvin-alcohol interaction Ann Emerg Med 24 1994 95 97
34. Fungizone Oral Suspension package insert prescribing information 1996 Bristol-Myers Squibb Immunology Princeton, NJ
35. M.P. Gascon P. Dayer In vitro forecasting of drugs which may interfere with the biotransformation of midazolam Eur J Clin Pharmacol 41 1991 573 578
36. J.G.G. Gillum D.S. Israel R.E. Polk Pharmacokinetic drug interactions with antimicrobial agents [review] Clin Pharmacokinet 25 1993 450 482
37. A.M. Glynn R.L. Slaughter C. Brass Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion Clin Pharmacol Ther 39 1986 654 659
38. S.M. Grant S.P. Clissold Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses [published erratum appears in Drugs 40:862, 1990] Drugs 39 1990 877 916
39. Grisactin package insert prescribing information 1992 Wyeth-Ayerst Laboratories Philadelphia, PA
40. Hismanal package insert prescribing information 1996 Janssen Pharmaceutica Titusville, NJ
41. P.K. Honig D.C. Worham K. Zamani The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans Clin Pharmacol Ther 53 1993 630 636
42. G.S. Hughes S.F. Francom C.R. Spillers The effect of ketoconazole and transdermal estradiol on serum sex steroid hormone levels Eur J Clin Pharmacol 38 1990 555 560
43. K. Iwasaki H. Matsuda K. Nagase Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes Res Commun Chem Pathol Pharmacol 82 1993 209 216
44. H.D. Kerr Case report: Potentiation of warfarin by fluconazole Am J Med Sci 305 1993 164 165
45. K.T. Kivisto P.J. Neuvonen U. Klotz Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences Clin Pharmacokinet 27 1994 1 5
46. C.A. Knupp D.C. Brater J. Relue Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus J Clin Pharmacol 33 1993 912 917
47. H. Konishi K. Morita A. Yamaji Effect of fluconazole on theophylline disposition in humans Eur J Clin Pharmacol 46 1994 309 312
48. I. Kovacs P. Somos M. Hamori Examination of the potential interaction between ketoconazole (Nizoral) and oral contraceptives with special regard to products of low hormone content (Rigevidon, anteovin) Ther Hung 34 1986 167 170
49. Lamisil Tablet package insert prescribing information 1996 Sandoz Pharmaceuticals East Hanover, NJ
50. J.D. Lazar K.D. Wilner Drug interactions with fluconazole Rev Infect Dis 12 Suppl 3 1990 S327 S333
51. B.L. Lee S. Safrin Interactions and toxicities of drugs used in patients with AIDS [see comments; review] Clin Infect Dis 14 1992 773 779
52. R.S. Lees A.M. Lees Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole [letter] N Engl J Med 333 1995 664 665
53. S.G. Lim A.M. Sawyerr M. Hudson Short report: The absorption of fluconazole and itraconazole under conditions of low intragastric acidity [published erratum appears in Aliment Pharmacol Ther 1993 Oct; 7(5):587] Aliment Pharmacol Ther 7 1993 317 321
54. C.C. Long S.A. Hill R.C. Thomas Effect of terbinafine on the pharmacokinetics of cyclosporin in humans J Invest Dermatol 102 1994 740 743
55. D.B. May R.H. Drew K.C. Yedinak Effect of simultaneous didanosine administration on itraconazole absorption in healthy volunteers Pharmacotherapy 14 1994 509 513
56. R.H. Meyboom K. de Jonge H. Veentjer [Potentiation of digoxin by itraconazole] Ned Tijdschr Geneeskd 138 1994 2353 2356
57. B.P. Monahan C.L. Ferguson E.S. Killeavy Torsades de pointes occurring in association with terfenadine use [see comments] JAMA 264 1990 2788 2790
58. P.J. Neuvonen R. Suhonen Itraconazole interacts with felodipine J Am Acad Dermatol 33 1995 134 135
59. P.J. Neuvonen K. Jalava Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid Clin Pharmacol Ther 1996 54 61
60. Nizoral package insert prescribing information 1995 Janssen Pharmaceutica Titusville, NJ
61. Nizoral (ketoconazole) section C.M. Krogh Compendium of Pharmaceutical and Specialties 1996 CK Productions Toronto 903 997
62. Norvir package insert prescribing information 1996 Abbott Laboratories North Chicago, IL
63. K. Okino R.T. Weibert Warfarin-griseofulvin interaction Drug Intel Clin Pharm 20 1986 291 293
64. P.N. Patsalos J.S. Duncan Antiepileptic drugs. A review of clinically significant drug interactions Drug Safety 9 1993 156 184
65. J.R. Perfect M.H. Lindsay R.H. Drew Adverse drug reactions to systemic antifungals. Prevention and management Drug Safety 7 1992 323 363
66. K.R. Phillips S.D. Wideman E.B. Cochran Griseofulvin significantly decreases serum salicylate concentrations Pediatr Infect Dis J 12 1993 350 352
67. P.I. Pillans M.J. Sparrow Pregnancy associated with a combined oral contraceptive and itraconazole [letter] N Z Med J 106 1993 436
68. S.C. Piscitelli T.F. Goss J.H. Wilton Effects of ranitidine and sucralfate on ketoconazole bioavailability Antimicrob Agents Chemother 35 1991 1765 1771
69. Prevacid package insert prescribing information 1995 Tap Pharmaceuticals Deerfield, IL
70. Prograf package insert prescribing information 1995 Fujisawa USA Deerfield, IL
71. Propusid package insert prescribing information 1995 Janssen Pharmaceutica Titusville, NJ
72. D.I. Quinn R.O. Day Drug interactions of clinical importance. An updated guide Drug Safety 12 1995 393 452
73. E. Rampini L. Schiazza C. Occella Falsely elevated urinary level of vanillylmandelic acid induced by griseofulvin Arch Dermatol 125 1989 269 270
74. T. Rosen Debilitating edema associated with itraconazole therapy [letter] Arch Dermatol 130 1994 260 261
75. S.J. Rossi T.J. Schroeder S. Hariharan Prevention and management of the adverse effects associated with immunosuppressive therapy Drug Safety 9 1993 104 131
76. J. Sahai K. Gallicano A. Pakuts Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus J Infect Dis 169 1994 1103 1107
77. Sandimmune package insert prescribing information 1995 Sandoz Pharmaceuticals East Hanover, NJ
78. Sandoz Pharmaceuticals, data on file 1996 East Hanover NJ
79. A. Schaffner A. Bohler Amphotericin B refractory aspergillosis after itraconazole: Evidence for significant antagonism Mycoses 36 1993 421 424
80. Seldane package insert prescribing information 1995 Hoechst Marion Roussel Kansas City, MO
81. G.M. Shenfield J.M. Griffin Clinical pharmacokinetics of contraceptive steroids. An update [review] Clin Pharmacokinet 20 1991 15 37
82. R.L. Slaughter D.J. Edwards Recent advances: The cytochrome P450 enzymes Ann Pharmacother 29 1995 619 624
83. M. Spatzenegger W. Jaeger Clinical importance of hepatic cytochrome P450 in drug metabolism Drug Metab Rev 27 1995 397 417
84. Sporanox package insert prescribing information 1996 Janssen Pharmaceutica Titusville, NJ
85. S.A. Tailor A.K. Gupta S.E. Walker Peripheral edema due to nifedipine-itraconazole interaction: A case report [letter] Arch Dermatol 132 1996 350 352
86. S. Tett D. Carey H.S. Lee Drug interactions with fluconazole [letter] Med J Aust 156 1992 365
87. D. Thompson G. Oster Use of terfenadine and contraindicated drugs JAMA 275 1996 1339 1341
88. R.M. Tucker D.W. Denning L.H. Hanson Interaction of azoles with rifampin, phenytoin, and carbamazepine: In vitro and clinical observations Clin Infect Dis 14 1992 165 174
89. B. Ulrich F.J. Frey R.F. Speck Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction J Pharmacol Exp Ther 260 1992 487 490
90. Xanax package insert prescribing information 1996 Pharmacia & Upjohn Company Kalamazoo, MI
91. J. Yeh S.C. Soo C. Summerton Potentiation of action of warfarin by itraconazole BMJ 301 1990 669
92. R.M. Zurcher B.M. Frey F.J. Frey Impact of ketoconazole on the metabolism of prednisolone [see comments] Clin Pharmacol Ther 45 1989 366 372